You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 7, July 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Patient-Physician Communication
 •Treatment Adherence
 •Psychopharmacology
 •Drug Therapy
 •Schizophrenia
 •Adherence
 •Alert me on articles by topic

Attitudes Toward Antipsychotic Medication

The Impact of Clinical Variables and Relationships With Health Professionals

Jennifer C. Day, PhD; Richard P. Bentall, PhD; Chris Roberts, PhD; Fiona Randall, BSc; Anne Rogers, PhD; Dinah Cattell, RMN; David Healy, MD; Pam Rae, BSc; Cheryl Power, MSc

Arch Gen Psychiatry. 2005;62:717-724.

Context  Nonadherence to antipsychotic medication is a major cause of psychotic relapse and is strongly influenced by attitudes toward treatment. Although patient variables such as insight and symptoms that contribute toward attitudes have been identified, the contributions of relationship and service factors have not been adequately studied.

Objective  To determine relations between clinical and service variables and attitudes toward medication in people with a diagnosis of schizophrenia and schizoaffective disorder.

Design  Consecutively admitted patients were approached to take part; 23 refused. Measures included symptoms, insight, drug adverse effects, self-reported adherence, attitudes toward treatment, perceived relationship with the prescriber, ward atmosphere, and admission experience. Data were analyzed by a proportional odds model and structural equation modeling to test predicted paths between experience of admission, relationship variables, attitudes toward treatment, and self-reported adherence to medication.

Setting  Twenty-eight inpatient wards at 8 hospitals in North Wales and the Northwest of England. Sites included hospitals with inner-city and rural catchment areas.

Patients  Two hundred twenty-eight patients meeting DSM-IV criteria for schizophrenia or schizoaffective disorder, assessed during acute admission.

Main Outcome Measures  Attitudes toward treatment and self-reported adherence to medication.

Results  The data fit a model in which attitudes toward treatment were predicted by insight, relationship with staff (especially the physician-prescriber), and the patient’s admission experience (maximum likelihood {chi}249 = 89.3, P<.001). A poor relationship with the prescriber, experience of coercion during admission, and low insight predicted a negative attitude toward treatment.

Conclusions  The quality of relationships with clinicians during acute admission appears to be an important determinant of patients’ attitudes toward treatment and adherence to medication. Enhancing such relationships may yield important clinical benefits.


Author Affiliations: Pharmacy Department, Mersey Care NHS Trust, Merseyside, England (Dr Day); School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, England (Dr Day); Department of Psychology (Dr Bentall), Biostatistics Group, School of Epidemiology and Health Sciences (Dr Roberts), and National Primary Care Research and Development Centre (Dr Rogers), University of Manchester, Manchester, England; North Wales Clinical Psychology Department, University of Wales, Bangor (Ms Randall); Division of Psychological Medicine, North Wales Department, Wales College of Medicine, Cardiff University, Cardiff (Ms Cattell and Dr Healy); and Department of Clinical Psychology, University of Liverpool, Liverpool (Mss Rae and Power).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
Kumra et al.
Schizophr Bull 2008;34:60-71.
ABSTRACT | FULL TEXT  

Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review
Lincoln et al.
Schizophr Bull 2007;33:1324-1342.
ABSTRACT | FULL TEXT  

Patient-reported outcomes in schizophrenia
McCabe et al.
Br. J. Psychiatry 2007;191:s21-s28.
ABSTRACT | FULL TEXT  

Understanding and Preventing Criminal Recidivism Among Adults With Psychotic Disorders
Lamberti
Psychiatr. Serv. 2007;58:773-781.
ABSTRACT | FULL TEXT  

Differential Medication Adherence Among Patients With Schizophrenia and Comorbid Diabetes and Hypertension
Piette et al.
Psychiatr. Serv. 2007;58:207-212.
ABSTRACT | FULL TEXT  

Helping patients with paranoid and suspicious thoughts: a cognitive-behavioural approach
Freeman and Garety
Adv. Psychiatr. Treat. 2006;12:404-415.
ABSTRACT | FULL TEXT  

Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Velligan et al.
Schizophr Bull 2006;32:724-742.
ABSTRACT | FULL TEXT  

Recent Advances in Social Skills Training for Schizophrenia
Kopelowicz et al.
Schizophr Bull 2006;32:S12-S23.
ABSTRACT | FULL TEXT  

The Illness Management and Recovery Program: Rationale, Development, and Preliminary Findings
Mueser et al.
Schizophr Bull 2006;32:S32-S43.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.